This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Should You Buy China ETFs as Coronavirus Cases Wane?
by Sweta Jaiswal, FRM
The coronavirus outbreak seems to be slowing down in the world's second largest economy.
ETFs at Risk as Coronavirus Hits China's Economy Hard
by Sweta Jaiswal, FRM
The latest economic data reveals how damaging the coronavirus outbreak has been for China's economy.
ETFs to Suffer as China's Q1 Growth Outlook Gets Gloomier
by Sweta Jaiswal, FRM
Analysts are getting more pessimistic about China's economic growth in the first quarter of 2020 as the coronavirus outbreak continues to intensify globally.
Will China ETFs Suffer as Coronavirus Dents Factory Output?
by Sweta Jaiswal, FRM
China's manufacturing output PMI hit the lowest level in record in February primarily due to the coronavirus outbreak.
Coronavirus Triggers Market Bloodbath: 7 Hot Inverse ETF Areas
by Sanghamitra Saha
A rise in coronavirus cases outside China has intensified the scare for global markets. These inverse ETFs posted solid gains.
Can China ETFs Gain on New Stimulus to Combat Covid-19?
by Sweta Jaiswal, FRM
China's policymakers inject more stimuli to support the world's second largest economy in the wake of aggravating coronavirus outbreak.
Alibaba Fiscal Q3 Earnings Put These ETFs in Focus
by Sweta Killa
Alibaba reported strong third-quarter fiscal 2020 results, wherein it beat earnings and revenue expectations.
China ETFs to Gain on New Stimuli to Combat Coronavirus
by Sweta Jaiswal, FRM
China's introduction of fresh stimuli to fight the impact of coronavirus on the economy instills confidence in investors.
Can China ETFs Survive the Coronavirus Onslaught?
by Sweta Jaiswal, FRM
Coronavirus is spreading at an alarming rate in China, posing a serious threat to financial markets and economic growth.
10 ETFs for 2020
by Neena Mishra
Here are some interesting ETF picks for the year.